Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy

BJU International

Volumn 110, Issue 11 C, 2012, Pages

  Kimura, Masaki ^a   Caso, Jorge R ^a   Bañez, Lionel L ^a   Koontz, Bridget F ^b   Gerber, Leah ^a   Senocak, Cagri ^a   Donatucci, Craig F ^a   Vujaskovic, Zeljko ^b   Moul, Judd W ^a   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Erectile dysfunction; Penile rehabilitation; Prostate cancer; Radical prostatectomy; Sexual function

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PENILE REHABILITATION PROGRAM; PENIS ERECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; REHABILITATION CARE; SCORING SYSTEM; SEXUAL FUNCTION; UROLOGICAL THERAPEUTIC DEVICE; VACUUM ERECTION DEVICE; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; MIDDLE AGED; ORGANIC IMPOTENCE; PATIENT COMPLIANCE; PENIS; PENIS PROSTHESIS; PHYSIOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VACUUM;

FOLLOW-UP STUDIES; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PENILE ERECTION; PENILE PROSTHESIS; PENIS; PHOSPHODIESTERASE 5 INHIBITORS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VACUUM;

MLCS; MLOWN;

EID: 84873272603     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11168.x     Document Type: Article

References (39)

1. Jemal A, Siegel R, Xu J, Ward E . Cancer statistics, 2010 . CA Cancer J Clin 2010 ; 60 : 277-300
2. Stanford JL, Feng Z, Hamilton AS et al . Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study . JAMA 2000 ; 283 : 354-60 (Pubitemid 30051753)
3. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM . Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor . Urology 1999 ; 54 : 503-8 (Pubitemid 29407029)
4. Kimura M, Banez LL, Schroeck FR et al . Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy . J Sex Med 2011 ; 8 : 2935-43
5. Teloken P, Mesquita G, Montorsi F, Mulhall J . Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners . J Sex Med 2009 ; 6 : 2032-8
6. Bergman J, Gore JL, Penson DF, Kwan L, Litwin MS . Erectile aid use by men treated for localized prostate cancer . J Urol 2009 ; 182 : 649-54
7. Pahlajani G, Raina R, Jones S, Ali M, Zippe C . Vacuum erection devices revisited: its emerging role in the treatment of erectile dysfunction and early penile rehabilitation following prostate cancer therapy . J Sex Med 2010 ; [ Epub ahead of print ] . DOI: 10.1111/j.1743-6109.2010.01881.x
8. Mulhall JP, Muller A, Donohue JF et al . The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafi l citrate . J Sex Med 2008 ; 5 : 1126-36 (Pubitemid 351606701)
9. Kovanecz I, Rambhatla A, Ferrini M et al . Long-term continuous sildenafi l treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats . I nt J Impot Res 2008 ; 2 0 : 202-12 (Pubitemid 351374330)
10. Vignozzi L, Filippi S, Morelli A et al . Effect of chronic tadalafi l administration on penile hypoxia induced by cavernous neurotomy in the rat . J Sex Med 2006 ; 3 : 419-31
11. Ferrini MG, Davila HH, Kovanecz I, Sanchez SP, Gonzalez-Cadavid NF, Rajfer J . Vardenafi l prevents fi brosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat . Urology 2006 ; 68 : 429-35 (Pubitemid 44175524)
12. Vignozzi L, Morelli A, Filippi S et al . Effect of sildenafi l administration on penile hypoxia induced by cavernous neurotomy in the rat . Int J Impot Res 2008 ; 20 : 60-7
13. Mulhall JP . The role and structure of a postradical prostatectomy penile rehabilitation program . Curr Urol Rep 2009 ; 10 : 219-25
14. Watkins Bruner D, James JL, Bryan CJ et al . Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafi l after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215 . J Sex Med 2011 ; 8 : 1228-38
15. Montorsi F, Brock G, Lee J et al . Effect of nightly versus on-demand vardenafi l on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy . Eur Urol 2008 ; 54 : 924-31
16. Hatzimouratidis K, Moysidis K, Bekos A, Tsimtsiou Z, Ioannidis E, Hatzichristou D . Treatment strategy for ' non-responders ' to tadalafi l and vardenafi l: a real-life study . Eur Urol 2006 ; 50 : 126-33 (Pubitemid 43850118)
17. Kohler TS, Pedro R, Hendlin K et al . A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy . BJU Int 2007 ; 100 : 858-62 (Pubitemid 47360201)
18. McCullough AR . Rehabilitation of erectile function following radical prostatectomy . Asian J Androl 2008 ; 10 : 61-74
19. Raina R, Pahlajani G, Agarwal A, Jones S, Zippe C . Long-term potency after early use of a vacuum erection device following radical prostatectomy . BJU Int 2010 ; 106 : 1719-22
20. Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP. Phosphodiesterase type inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application . Eur Urol 2009 ; 55 : 334-47
21. Yuan J, Lin H, Li P et al . Molecular mechanisms of vacuum therapy in penile rehabilitation: a novel animal study . Eur Urol 2010 ; 58 : 773-80
22. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG . Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of healthrelated quality of life in men with prostate cancer . Urology 2000 ; 56 : 899-905
23. Hu JC, Elkin EP, Pasta DJ et al . Predicting quality of life after radical prostatectomy: results from CaPSURE . J Urol 2004 ; 171 : 703-8
24. Haffner MC, Landis PK, Saigal CS, Carter HB, Freedland SJ . Health-related quality-of-life outcomes after anatomic retropubic radical prostatectomy in the phosphodiesterase type 5 ERA: impact of neurovascular bundle preservation . Urology 2005 ; 66 : 371-6 (Pubitemid 41138100)
25. Defade BP, Carson CC 3rd, Kennelly MJ . Postprostatectomy erectile dysfunction: the role of penile rehabilitation . R ev Urol 2011 ; 1 3 : 6-13
26. Salonia A, Gallina A, Zanni G et al . Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nervesparing radical prostatectomy . Eur Urol 2008 ; 53 : 564-70 (Pubitemid 351178991)
27. Banez LL, Terris MK, Aronson WJ et al . Race and time from diagnosis to radical prostatectomy: does equal access mean equal timely access to the operating room? Results from the SEARCH database . Cancer Epidemiol Biomarkers Prev 2009 ; 18 : 1208-12
28. Freedland SJ, Isaacs WB . Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate 2005 ; 62 : 243-52
29. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT . Factors predicting recovery of erections after radical prostatectomy . J Urol 2000 ; 164 : 1929-34
30. Marien T, Sankin A, Lepor H . Factors predicting preservation of erectile function in men undergoing open radical retropubic prostatectomy . J Urol 2009 ; 181 : 1817-22
31. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP . Erectile function recovery rate after radical prostatectomy: a meta-analysis . J Sex Med 2009 ; 6 : 2538-46
32. Muller A, Parker M, Waters BW, Flanigan RC, Mulhall JP . Penile rehabilitation following radical prostatectomy: predicting success . J Sex Med 2009 ; 6 : 2806-12
33. DiBlasio CJ, Malcolm JB, Derweesh IH et al . Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer . BJU Int 2008 ; 102 : 39-43 (Pubitemid 351799441)
34. Fowler FJ Jr, McNaughton Collins M, Walker Corkery E, Elliott DB, Barry MJ . The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma . Cancer 2002 ; 95 : 287-95 (Pubitemid 34787594)
35. Sharifi N, Gulley JL, Dahut WL . Androgen deprivation therapy for prostate cancer . JAMA 2005 ; 294 : 238-44 (Pubitemid 41043794)
36. Pahlajani G, Raina R, Jones JS et al . Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function . BJU Int 2010 ; 106 : 1524-7
37. Incrocci L, Slagter C, Slob AK, Hop WC . A randomized, double-blind, placebo-controlled, cross-over study to assess the effi cacy of tadalafi l (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma . Int J Radiat Oncol Biol Phys 2006 ; 66 : 439-44 (Pubitemid 44332743)
38. Ficarra V, Novara G, Fracalanza S et al . A prospective, non-randomized trial comparing robot-assisted laparoscopic and retropubic radical prostatectomy in one European institution . BJU Int 2009 ; 104 : 534-9
39. Di Pierro GB, Baumeister P, Stucki P, Beatrice J, Danuser H, Mattei A . A prospective trial comparing consecutive series of open retropubic and robotassisted laparoscopic radical prostatectomy in a centre with a limited caseload . Eur Urol 2011 ; 59 : 1-6